US Stock MarketDetailed Quotes

Vivos Therapeutics (VVOS)

Watchlist
  • 0.896
  • -0.134-13.02%
Close Apr 23 16:00 ET
  • 0.896
  • +0.000+0.01%
Post 16:19 ET
12.08MMarket Cap-0.43P/E (TTM)

Vivos Therapeutics (VVOS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-20.27%-15.26M
-29.66%-3.81M
0.62%-4.16M
-14.63%-3.49M
-50.87%-3.8M
-6.24%-12.69M
-6.99%-2.94M
-49.54%-4.19M
-6.61%-3.05M
28.91%-2.52M
Net income from continuing operations
-90.64%-21.23M
-145.99%-6.95M
-106.30%-5.4M
-159.88%-5.01M
-2.68%-3.86M
18.02%-11.14M
33.62%-2.83M
-25.04%-2.62M
65.10%-1.93M
-120.96%-3.76M
Operating gains losses
----
----
----
----
----
101.02%31K
-97.70%5K
100.34%6K
-98.67%14K
100.24%6K
Depreciation and amortization
125.30%1.31M
206.94%442K
163.01%384K
111.03%306K
21.23%177K
-6.44%581K
-3.36%144K
-2.01%146K
-2.03%145K
-16.57%146K
Other non cash items
----
----
--0
----
----
-87.36%11K
--0
--0
----
----
Change In working capital
235.95%4M
963.01%2.75M
142.86%799K
155.87%871K
-153.12%-426K
-202.65%-2.94M
-135.21%-319K
-361.43%-1.86M
-254.05%-1.56M
244.21%802K
-Change in receivables
4.82%-217K
2,204.17%553K
-749.15%-501K
-85.50%19K
11.11%-288K
-189.41%-228K
-7.69%24K
-159.60%-59K
2,283.33%131K
-338.24%-324K
-Change in prepaid assets
177.42%48K
-162.07%-228K
246.15%114K
-78.57%-75K
63.45%237K
-106.80%-62K
-157.24%-87K
-125.49%-78K
-115.38%-42K
-19.89%145K
-Change in payables and accrued expense
481.05%4.14M
943.12%2.88M
175.19%782K
201.61%822K
-170.16%-341K
-194.03%-1.09M
-72.29%276K
-597.61%-1.04M
-402.48%-809K
333.93%486K
-Change in other current liabilities
517.05%538K
-1,087.88%-392K
1,196.88%351K
489.09%214K
4,155.56%365K
-111.20%-129K
59.26%-33K
-129.63%-32K
-104.66%-55K
83.93%-9K
-Change in other working capital
64.16%-514K
88.18%-59K
108.09%53K
86.10%-109K
-179.17%-399K
-134.70%-1.43M
-166.84%-499K
-7,177.78%-655K
-185.09%-784K
460.00%504K
Cash from discontinued investing activities
Operating cash flow
-20.27%-15.26M
-29.66%-3.81M
0.62%-4.16M
-14.63%-3.49M
-50.87%-3.8M
-6.24%-12.69M
-6.99%-2.94M
-49.54%-4.19M
-6.61%-3.05M
28.91%-2.52M
Investing cash flow
Cash flow from continuing investing activities
-1,225.00%-7.53M
-858.18%-1.58M
143.23%83K
-9,743.33%-5.91M
19.21%-122K
33.41%-568K
0.00%-165K
-24.68%-192K
75.51%-60K
47.75%-151K
Net PPE purchase and sale
-312.15%-2.34M
-827.88%-1.53M
143.23%83K
-1,185.00%-771K
19.21%-122K
29.27%-568K
0.00%-165K
-24.68%-192K
75.51%-60K
36.82%-151K
Net business purchase and sale
---5.19M
---50K
--0
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-1,225.00%-7.53M
-858.18%-1.58M
143.23%83K
-9,743.33%-5.91M
19.21%-122K
33.41%-568K
0.00%-165K
-24.68%-192K
75.51%-60K
47.75%-151K
Financing cash flow
Cash flow from continuing financing activities
3.82%18.56M
41.94%4.34M
-27.04%2.76M
54.86%11.46M
0
63.65%17.88M
-14.41%3.05M
3.79M
7.4M
-50.58%3.64M
Net issuance payments of debt
--10.65M
--1.53M
---531K
----
----
--0
--0
--0
----
----
Net common stock issuance
-28.48%5.58M
-19.97%2.8M
-43.48%2.43M
----
----
94.90%7.8M
-12.50%3.5M
--4.3M
----
----
Proceeds from stock option exercised by employees
-72.26%3.17M
--0
--866K
-69.23%2.31M
--0
43.01%11.44M
--0
--0
--7.5M
-50.74%3.94M
Net other financing activities
38.50%-837K
--0
--0
----
----
-26.37%-1.36M
-3.24%-446K
---509K
---100K
52.56%-306K
Cash from discontinued financing activities
Financing cash flow
3.82%18.56M
41.94%4.34M
-27.04%2.76M
54.86%11.46M
--0
63.65%17.88M
-14.41%3.05M
--3.79M
--7.4M
-50.58%3.64M
Net cash flow
Beginning cash position
281.01%6.26M
-51.09%3.09M
-36.23%4.4M
-10.30%2.34M
281.01%6.26M
-53.31%1.64M
538.77%6.31M
75.11%6.9M
-62.94%2.61M
-53.31%1.64M
Current changes in cash
-191.64%-4.23M
-1,974.51%-1.06M
-122.13%-1.32M
-52.00%2.06M
-504.75%-3.92M
346.11%4.62M
-107.79%-51K
79.96%-592K
238.27%4.29M
-72.55%968K
End cash Position
-67.59%2.03M
-67.59%2.03M
-51.09%3.09M
-36.23%4.4M
-10.30%2.34M
281.01%6.26M
281.01%6.26M
538.77%6.31M
75.11%6.9M
-62.94%2.61M
Free cash flow
-32.77%-17.6M
-72.08%-5.34M
6.87%-4.08M
-37.23%-4.27M
-46.91%-3.92M
-4.00%-13.26M
-6.59%-3.11M
-48.24%-4.38M
-0.13%-3.11M
29.41%-2.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -20.27%-15.26M-29.66%-3.81M0.62%-4.16M-14.63%-3.49M-50.87%-3.8M-6.24%-12.69M-6.99%-2.94M-49.54%-4.19M-6.61%-3.05M28.91%-2.52M
Net income from continuing operations -90.64%-21.23M-145.99%-6.95M-106.30%-5.4M-159.88%-5.01M-2.68%-3.86M18.02%-11.14M33.62%-2.83M-25.04%-2.62M65.10%-1.93M-120.96%-3.76M
Operating gains losses --------------------101.02%31K-97.70%5K100.34%6K-98.67%14K100.24%6K
Depreciation and amortization 125.30%1.31M206.94%442K163.01%384K111.03%306K21.23%177K-6.44%581K-3.36%144K-2.01%146K-2.03%145K-16.57%146K
Other non cash items ----------0---------87.36%11K--0--0--------
Change In working capital 235.95%4M963.01%2.75M142.86%799K155.87%871K-153.12%-426K-202.65%-2.94M-135.21%-319K-361.43%-1.86M-254.05%-1.56M244.21%802K
-Change in receivables 4.82%-217K2,204.17%553K-749.15%-501K-85.50%19K11.11%-288K-189.41%-228K-7.69%24K-159.60%-59K2,283.33%131K-338.24%-324K
-Change in prepaid assets 177.42%48K-162.07%-228K246.15%114K-78.57%-75K63.45%237K-106.80%-62K-157.24%-87K-125.49%-78K-115.38%-42K-19.89%145K
-Change in payables and accrued expense 481.05%4.14M943.12%2.88M175.19%782K201.61%822K-170.16%-341K-194.03%-1.09M-72.29%276K-597.61%-1.04M-402.48%-809K333.93%486K
-Change in other current liabilities 517.05%538K-1,087.88%-392K1,196.88%351K489.09%214K4,155.56%365K-111.20%-129K59.26%-33K-129.63%-32K-104.66%-55K83.93%-9K
-Change in other working capital 64.16%-514K88.18%-59K108.09%53K86.10%-109K-179.17%-399K-134.70%-1.43M-166.84%-499K-7,177.78%-655K-185.09%-784K460.00%504K
Cash from discontinued investing activities
Operating cash flow -20.27%-15.26M-29.66%-3.81M0.62%-4.16M-14.63%-3.49M-50.87%-3.8M-6.24%-12.69M-6.99%-2.94M-49.54%-4.19M-6.61%-3.05M28.91%-2.52M
Investing cash flow
Cash flow from continuing investing activities -1,225.00%-7.53M-858.18%-1.58M143.23%83K-9,743.33%-5.91M19.21%-122K33.41%-568K0.00%-165K-24.68%-192K75.51%-60K47.75%-151K
Net PPE purchase and sale -312.15%-2.34M-827.88%-1.53M143.23%83K-1,185.00%-771K19.21%-122K29.27%-568K0.00%-165K-24.68%-192K75.51%-60K36.82%-151K
Net business purchase and sale ---5.19M---50K--0----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow -1,225.00%-7.53M-858.18%-1.58M143.23%83K-9,743.33%-5.91M19.21%-122K33.41%-568K0.00%-165K-24.68%-192K75.51%-60K47.75%-151K
Financing cash flow
Cash flow from continuing financing activities 3.82%18.56M41.94%4.34M-27.04%2.76M54.86%11.46M063.65%17.88M-14.41%3.05M3.79M7.4M-50.58%3.64M
Net issuance payments of debt --10.65M--1.53M---531K----------0--0--0--------
Net common stock issuance -28.48%5.58M-19.97%2.8M-43.48%2.43M--------94.90%7.8M-12.50%3.5M--4.3M--------
Proceeds from stock option exercised by employees -72.26%3.17M--0--866K-69.23%2.31M--043.01%11.44M--0--0--7.5M-50.74%3.94M
Net other financing activities 38.50%-837K--0--0---------26.37%-1.36M-3.24%-446K---509K---100K52.56%-306K
Cash from discontinued financing activities
Financing cash flow 3.82%18.56M41.94%4.34M-27.04%2.76M54.86%11.46M--063.65%17.88M-14.41%3.05M--3.79M--7.4M-50.58%3.64M
Net cash flow
Beginning cash position 281.01%6.26M-51.09%3.09M-36.23%4.4M-10.30%2.34M281.01%6.26M-53.31%1.64M538.77%6.31M75.11%6.9M-62.94%2.61M-53.31%1.64M
Current changes in cash -191.64%-4.23M-1,974.51%-1.06M-122.13%-1.32M-52.00%2.06M-504.75%-3.92M346.11%4.62M-107.79%-51K79.96%-592K238.27%4.29M-72.55%968K
End cash Position -67.59%2.03M-67.59%2.03M-51.09%3.09M-36.23%4.4M-10.30%2.34M281.01%6.26M281.01%6.26M538.77%6.31M75.11%6.9M-62.94%2.61M
Free cash flow -32.77%-17.6M-72.08%-5.34M6.87%-4.08M-37.23%-4.27M-46.91%-3.92M-4.00%-13.26M-6.59%-3.11M-48.24%-4.38M-0.13%-3.11M29.41%-2.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M Show More